Femistra 1 mg Zydus Healthcare Ltd.
€30.00
About Femistra 1 mg Zydus Healthcare Ltd.
Femistra 1 mg, produced by Zydus Healthcare Ltd., is a pharmaceutical formulation that primarily contains the active ingredient Letrozole. This medication is commonly utilized in the treatment of hormone receptor-positive breast cancer among postmenopausal women. Femistra is often categorized within the class of aromatase inhibitors, functioning by significantly lowering estrogen levels in the body. This reduction is beneficial in slowing or stopping the growth of certain breast tumors that require estrogen to grow. The composition of Femistra includes not only Letrozole but also excipients that assist in the tablet’s stability and absorption. Patients and athletes often seek this medication for its potential off-label uses, especially in the realm of sports pharmacology.
How Femistra 1 mg Zydus Healthcare Ltd. works, impact on physical performance
The mechanism of action for Femistra involves the inhibition of aromatase, an enzyme responsible for converting androgens into estrogens in the body. By blocking this process, Femistra lowers estrogen production, thereby creating a hormonal environment less conducive to the growth of certain cancers. For athletes, this reduction in estrogen can lead to an increase in muscle mass and strength, making it appealing among competitors looking to enhance their performance. However, it’s crucial to understand that while this medication may have some positive effects on muscle gain and physical performance, it also may bring risks of side effects, such as bone density loss and cardiovascular issues. The balance between benefits and risks needs to be assessed meticulously, making consultation with a healthcare professional essential prior to use.
Benefits, faster recovery and endurance
Athletes utilizing Femistra may experience a variety of benefits linked to improved physical performance. One noted advantage is faster recovery periods following intense workouts, which allows athletes to train more effectively and consistently. Additionally, as Femistra promotes a more favorable hormonal balance, users may find enhancements in muscle endurance and strength. This characteristic can lead them to push their limits during training sessions, ultimately contributing to better overall performance in competitions. Furthermore, the potential increase in lean muscle mass may be particularly attractive for those in strength-dependent sports. However, users should be aware that the use of such medications can impart a regulatory risk, as anti-doping agencies may classify Femistra as a prohibited substance, which could carry significant consequences in professional sporting environments.
Buy Femistra 1 mg Zydus Healthcare Ltd. in our shop, fast payment and reliable shipping
For those interested in purchasing Femistra 1 mg, our online shop provides a convenient platform for acquiring this medication. We ensure a seamless shopping experience, from fast payment options to reliable shipping services. Our commitment to quality means that you can trust our sources and the authenticity of the products we offer. We also prioritize customer satisfaction, providing support and information throughout your purchase journey. Whether you are a competitive athlete or someone considering Femistra for other medical uses, our shop is designed to meet your needs efficiently and securely.
Safety notes
While Femistra presents potential benefits, safety should always be a paramount concern. Here are several important recommendations to consider:
- Consult with a healthcare provider before starting Femistra, especially if you have pre-existing conditions.
- Be aware of the potential side effects, including joint pain, hot flashes, and cardiovascular risks.
- Regularly monitor bone health, as prolonged use can lead to decreased bone density.
- Employ a balanced diet and exercise regimen to counteract any adverse effects on physical well-being.
- Always check the legality of Femistra use in your respective sport to avoid violations of anti-doping regulations.
- Avoid combining Femistra with other anabolic substances without medical advice due to unpredictable interactions.
Using Femistra requires careful consideration and a commitment to safety, ensuring that the pursuit of performance enhancement does not come at a significant health cost.
| Active substance | Anastrozole |
|---|---|
| Active Half-Life | 2 days |
| Classification | Non-steroidal aromatase inhibitor |
| Dosage | 0.5-1 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitors estrogen levels and liver function |
| Also known as | Anastrol, Anastrozolo |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can cause changes in blood pressure, monitor regularly |
| Trade name | Arimidex |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropanenitrile) |
| Formula | C17H19N5 |
| Substance class | Aromatase inhibitor |
| Main action | Inhibits enzyme aromatase, reducing estrogen production |
| Half-life | 46.8 hours |
| Dosage (medical) | 1 mg once daily |
| Dosage (sports) | Not officially recommended, varies widely, typically 0.5 mg to 1 mg every other day |
| Effects | Reduces estrogen levels, increases testosterone levels |
| Side effects | Hot flashes, joint stiffness or pain, weakness, sore throat, depression, nausea, and vomiting |
| Use in sports | Used to control estrogen levels and prevent gynecomastia in anabolic steroid users |
| Manufacturer | Zydus Pharma |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |


Reviews
There are no reviews yet.